BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 29184809)

  • 1. Review of Prader-Willi syndrome: the endocrine approach.
    Heksch R; Kamboj M; Anglin K; Obrynba K
    Transl Pediatr; 2017 Oct; 6(4):274-285. PubMed ID: 29184809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prader-Willi syndrome: an update on obesity and endocrine problems.
    Kim SJ; Cho SY; Jin DK
    Ann Pediatr Endocrinol Metab; 2021 Dec; 26(4):227-236. PubMed ID: 34991300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prader-Willi syndrome: endocrine manifestations and management.
    Alves C; Franco RR
    Arch Endocrinol Metab; 2020; 64(3):223-234. PubMed ID: 32555988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prader- Willi syndrome: An uptodate on endocrine and metabolic complications.
    Muscogiuri G; Formoso G; Pugliese G; Ruggeri RM; Scarano E; Colao A;
    Rev Endocr Metab Disord; 2019 Jun; 20(2):239-250. PubMed ID: 31065942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine manifestations and management of Prader-Willi syndrome.
    Emerick JE; Vogt KS
    Int J Pediatr Endocrinol; 2013 Aug; 2013(1):14. PubMed ID: 23962041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
    Angulo MA; Butler MG; Cataletto ME
    J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
    Höybye C
    Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.
    Muscogiuri G; Barrea L; Faggiano F; Maiorino MI; Parrillo M; Pugliese G; Ruggeri RM; Scarano E; Savastano S; Colao A;
    J Endocrinol Invest; 2021 Oct; 44(10):2057-2070. PubMed ID: 33891302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity management in Prader-Willi syndrome: current perspectives.
    Crinò A; Fintini D; Bocchini S; Grugni G
    Diabetes Metab Syndr Obes; 2018; 11():579-593. PubMed ID: 30323638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.
    Correa-da-Silva F; Fliers E; Swaab DF; Yi CX
    J Neuroendocrinol; 2021 Jul; 33(7):e12994. PubMed ID: 34156126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome.
    McCarthy JM; McCann-Crosby BM; Rech ME; Yin J; Chen CA; Ali MA; Nguyen HN; Miller JL; Schaaf CP
    J Med Genet; 2018 May; 55(5):307-315. PubMed ID: 29496979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Profile and Molecular Genetic Analysis of Prader - Willi Syndrome: A Single Center Experience.
    Sridhar S; Nazirudeen R; Ramasamy S; Natarajan V; Thiagarajan K; Karthika LN
    Indian J Endocrinol Metab; 2022; 26(4):384-388. PubMed ID: 36185961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to the Patient With Prader-Willi Syndrome.
    Höybye C; Tauber M
    J Clin Endocrinol Metab; 2022 May; 107(6):1698-1705. PubMed ID: 35150573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
    Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
    Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of obesity in Prader-Willi syndrome.
    Khan MJ; Gerasimidis K; Edwards CA; Shaikh MG
    Pediatr Obes; 2018 Jan; 13(1):3-13. PubMed ID: 27863129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central adrenal insufficiency screening with morning plasma cortisol and ACTH levels in Prader-Willi syndrome.
    Angulo MA; Butler MG; Hossain WA; Castro-Magana M; Corletto J
    J Pediatr Endocrinol Metab; 2022 Jun; 35(6):733-740. PubMed ID: 35437976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypogonadism in Women with Prader-Willi Syndrome-Clinical Recommendations Based on a Dutch Cohort Study, Review of the Literature and an International Expert Panel Discussion.
    Pellikaan K; Ben Brahim Y; Rosenberg AGW; Davidse K; Poitou C; Coupaye M; Goldstone AP; Høybye C; Markovic TP; Grugni G; Crinò A; Caixàs A; Eldar-Geva T; Hirsch HJ; Gross-Tsur V; Butler MG; Miller JL; van der Kuy PM; van den Berg SAA; Visser JA; van der Lely AJ; de Graaff LCG
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine problems in children with Prader-Willi syndrome: special review on associated genetic aspects and early growth hormone treatment.
    Jin DK
    Korean J Pediatr; 2012 Jul; 55(7):224-31. PubMed ID: 22844316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal insufficiency in patients with Prader-Willi syndrome.
    Kusz MJ; Gawlik AM
    Front Endocrinol (Lausanne); 2022; 13():1021704. PubMed ID: 36465638
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.